June 02, 2017

Cellavision

We feel like a sitting duck on the markets.

“It’s waiting that helps you as an investor, and a lot of people just can’t stand to wait.” – Charlie Munger

CEVI.ST US4 (ISIN: SE0000683484)      

CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education.

Market: Stockholm

http://www.cellavision.com


Gain over the last quarter: +44.6 % 



Fair value: 200 SEK
Discount: 9.6%
Average yearly return: 61%
Outperformer

On May 5, 2017: Payment of dividend in the amount of SEK 1,50 per share

No comments:

Post a Comment